VJHemOnc is committed to improving our service to you

ASCO 2019 | Treatments to prevent relapse in AML

VJHemOnc is committed to improving our service to you

Charles Craddock

Here, Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, from the University of Birmingham, Birmingham, UK, outlines the therapeutic options that can help address relapse post-transplant in acute myeloid leukemia (AML). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter